workflow:
  id: pharma_drug_dev_acceleration
  title: Drug Development Acceleration Process
  department: Research & Development
  complexity: high
  participants:
  - Chief Scientific Officer
  - Clinical Operations Director
  - Regulatory Affairs Lead
  - Data Science Team
  - Manufacturing Lead
  - Quality Assurance
  trigger: New molecular entity identified with therapeutic potential
  steps:
  - step: 1
    actor: Chief Scientific Officer
    action: Evaluate target validation and initial compound screening results
    tools:
    - High-throughput screening systems
    - Molecular modeling software
    - Literature databases
    duration: 4 weeks
    outputs:
    - Go/no-go decision
    - Initial development roadmap
  - step: 2
    actor: Data Science Team
    action: Apply AI/ML models for lead optimization and ADMET prediction
    tools:
    - Computational chemistry platforms
    - Machine learning algorithms
    - QSAR models
    duration: 8 weeks
    outputs:
    - Optimized lead compounds
    - Predictive safety profiles
  - step: 3
    actor: Clinical Operations Director
    action: Design accelerated clinical development plan with adaptive trial protocols
    tools:
    - Clinical trial management systems
    - Regulatory guidance databases
    - Statistical analysis software
    duration: 6 weeks
    outputs:
    - Phase 1-3 trial protocols
    - Adaptive design frameworks
  - step: 4
    actor: Regulatory Affairs Lead
    action: Prepare and submit IND application with accelerated approval pathway
    tools:
    - Regulatory submission software
    - FDA/EMA guidance documents
    - Fast Track/Breakthrough Therapy applications
    duration: 12 weeks
    outputs:
    - IND submission package
    - Regulatory meeting requests
  - step: 5
    actor: Manufacturing Lead
    action: Develop scalable manufacturing process with continuous improvement
    tools:
    - Process development labs
    - Quality by design software
    - Supply chain optimization tools
    duration: 16 weeks
    outputs:
    - GMP manufacturing protocols
    - Scale-up validation data
  - step: 6
    actor: Quality Assurance
    action: Conduct integrated quality oversight throughout development lifecycle
    tools:
    - Quality management systems
    - Risk assessment frameworks
    - Audit trail software
    duration: Ongoing
    outputs:
    - Quality control specifications
    - Regulatory compliance documentation
  success_criteria: FDA approval achieved within 5 years from target identification
  failure_modes:
  - Safety signals in preclinical studies
  - Manufacturing scalability issues
  - Regulatory pathway rejection
